V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014601 | 260009968 | 1.67 | 129 | Curative (C) | 2016-05-05 | 2016-04-28 | Bendamustine + Obinutuzumab | 2 | N | 260008037 | BOP |
| 260014602 | 260009970 | 1.87 | 84.1 | Palliative (P) | 2018-06-16 | 2018-07-14 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260008106 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014603 | 260009971 | 1.7 | 60 | Palliative (P) | 2017-05-27 | 2017-06-11 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | N | 260008231 | IFOSFAMIDE + PACLITAXEL |
| 260014604 | 260009973 | 1.75 | 77 | null | 2018-08-16 | 2018-08-16 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260008244 | IVA |
| 260014605 | 260009974 | 1.87 | 81 | Neo-adjuvant (N) | 2016-10-29 | 2016-11-05 | CYCLOPHOSPHAMIDE | 02 | N | 260008282 | VAI |
| 260014606 | 260014728 | 0 | 88.1 | Palliative (P) | 2017-09-24 | 2017-10-22 | BLEOMYCIN + VINCRISTINE | 02 | N | 260008282 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014607 | 260009979 | 1.65 | 56.45 | Curative (C) | 2014-06-20 | 2014-12-27 | DHAP - R | 02 | N | 260008373 | GDP |
| 260014608 | 260009981 | null | 85.7 | Curative (C) | 2017-08-11 | 2017-12-16 | PMitCEBO | N | N | 260008455 | ACE (GERM CELL) |
| 260014609 | 260014731 | 1.67 | 95.6 | Curative (C) | 2015-09-23 | 2015-10-01 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260008540 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260014610 | 260014731 | 1.9 | 59.5 | Palliative (P) | 2016-07-21 | 2016-09-02 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | null | 260008540 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014611 | 260019115 | 1.62 | 84.3 | Palliative (P) | 2015-03-03 | 2015-04-08 | LIPOSOMAL DOXORUBICIN | null | null | 260008561 | TRASTUZUMAB |
| 260014612 | 260009986 | 1.76 | 83 | Curative (C) | 2018-08-04 | 2018-08-20 | Carboplatin + Etoposide IV 3 day | N | N | 260008571 | CARBOPLATIN + ETOPOSIDE |
| 260014613 | 260009987 | 1.74 | 67.4 | Adjuvant (A) | 2014-01-12 | 2014-01-12 | Alemtuz+Cyclophos+Fludara Allo | N | N | 260008643 | BLEOMYCIN |
| 260014614 | 260009988 | 1.62 | null | Curative (C) | null | 2018-01-21 | BLEOMYCIN + VINCRISTINE | null | null | 260008651 | RMS 2005 TRIAL |
| 260014615 | 260009988 | 1.73 | null | null | 2018-08-01 | 2018-08-02 | POMB | N | N | 260008651 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014616 | 260009989 | 1.77 | 81.5 | Disease modification (D) | 2017-07-23 | 2017-07-23 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260008705 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014617 | 260009991 | 1.81 | 80.6 | Curative (C) | 2019-02-06 | 2019-02-27 | EP | N | N | 260008733 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014618 | 260014735 | 1.78 | 57.7 | Adjuvant (A) | 2018-05-20 | 2018-05-20 | GEM-P | 02 | null | 260008733 | ABVD |
| 260014619 | 260018818 | 1.63 | 83.1 | Adjuvant (A) | 2016-07-05 | 2016-07-05 | FLAG + Idarubicin | 02 | N | 260008781 | OFATUMUMAB |
| 260014620 | 260014736 | 1.77 | 71.7 | Adjuvant (A) | null | 2017-03-29 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | null | 260008789 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014621 | 260014736 | 1.63 | null | Palliative (P) | 2019-06-30 | 2019-07-07 | IBRUTINIB | N | N | 260008789 | CYTARABINE HD + METHOTREXATE HD |
| 260014622 | 260009993 | null | 62.6 | Curative (C) | null | 2019-09-07 | LIPOSOMAL DOXORUBICIN | N | N | 260008822 | LIPOSOMAL DOXORUBICIN |
| 260014623 | 260009994 | 1.79 | 49 | Palliative (P) | 2018-06-19 | 2018-06-19 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260008835 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260014624 | 260009994 | 1.64 | 85.5 | Curative (C) | null | 2014-08-18 | Cisplatin 7 day | N | N | 260008835 | CHOP |
| 260014625 | 260009996 | 1.77 | 70.9 | null | 2015-05-07 | 2015-11-04 | IFOSFAMIDE + PACLITAXEL | null | null | 260008930 | BLEOMYCIN |
| 260014626 | 260009998 | 1.85 | 89 | Disease modification (D) | 2016-09-02 | 2016-10-02 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260008975 | BLEOMYCIN |
| 260014627 | 260010003 | null | 53.5 | Curative (C) | null | 2018-09-12 | Docetaxel + Trastuzumab (Maint) | null | null | 260009010 | CVP |
| 260014628 | 260014741 | 1.8 | 60.8 | null | 2018-07-26 | 2018-07-26 | Carboplatin + Thiotepa + Topotecan | 99 | null | 260009037 | VIP |
| 260014629 | 260010005 | null | 73.7 | Curative (C) | 2018-08-12 | 2018-08-15 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | null | 260009048 | CARBO + THIOTEPA + TOPOTECAN |
| 260014630 | 260010006 | 1.81 | 111.7 | Curative (C) | null | 2015-12-09 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260009056 | BLEOMYCIN |
| 260014631 | 260010009 | 1.59 | 55.4 | Curative (C) | 2017-01-15 | 2017-01-22 | FEC 60 or 75 | 02 | N | 260009099 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014632 | 260010010 | 1.85 | 49 | Curative (C) | 2015-12-07 | 2015-12-10 | CARBO + THIOTEPA + TOPOTECAN | 2 | Y | 260009143 | PACLITAXEL |
| 260014633 | 260010012 | null | 52.5 | Palliative (P) | 2016-11-29 | 2016-12-08 | BLEOMYCIN + VINCRISTINE | N | N | 260009188 | CHOP |
| 260014634 | 260014743 | 1.73 | 90 | Curative (C) | 2015-11-07 | 2015-11-07 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 2 | N | 260009288 | CARBO + THIOTEPA + TOPOTECAN |
| 260014635 | 260010014 | 1.57 | 111.8 | Adjuvant (A) | 2015-04-26 | 2015-09-21 | CYCLOPHOSPHAMIDE | 02 | null | 260009334 | TRASTUZUMAB |
| 260014636 | 260010016 | 1.79 | 0 | Curative (C) | 2019-01-18 | 2019-02-12 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 260009422 | CISPLATIN + EPIRUBICIN |
| 260014637 | 260014745 | 1.71 | null | Palliative (P) | 2017-02-21 | 2017-02-21 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 02 | N | 260009506 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260014638 | 260014745 | 1.62 | 70 | Curative (C) | 2017-04-16 | 2017-04-30 | TRASTUZUMAB | 02 | N | 260009506 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014639 | 260014747 | null | 52.5 | null | null | 2016-04-30 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260009538 | CHOP |
| 260014640 | 260010024 | 0 | 67 | Curative (C) | 2017-09-13 | 2017-10-14 | IFOSFAMIDE + PACLITAXEL | N | N | 260009572 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN |
| 260014641 | 260010025 | 1.8 | 86 | Palliative (P) | 2017-07-10 | 2017-10-29 | TRASTUZUMAB | N | N | 260009616 | CISPLATIN + RT |
| 260014642 | 260014748 | 1.78 | 80 | Curative (C) | 2018-12-11 | 2018-12-18 | TRASTUZUMAB | N | N | 260009649 | ICE |
| 260014643 | 260010026 | null | 71.4 | Disease modification (D) | 2015-11-16 | 2015-11-19 | CISPLATIN + IFOSFAMIDE + MESNA + VINBLASTINE | N | N | 260009710 | PACLITAXEL |
| 260014644 | 260010026 | 1.77 | 89.5 | null | 2015-12-03 | 2015-12-04 | EP | N | null | 260009710 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014645 | 260010027 | 1.81 | 68.4 | Curative (C) | 2018-03-29 | 2018-03-29 | VIP | null | null | 260009772 | BLEOMYCIN + VINCRISTINE |
| 260014646 | 260010030 | 1.5 | 53.2 | Curative (C) | 2016-07-14 | 2016-07-15 | CVP | 2 | N | 260009790 | BLEOMYCIN + VINCRISTINE |
| 260014647 | 260010031 | 1.83 | 73.8 | Palliative (P) | 2016-05-07 | 2016-06-10 | CISPLATIN + EPIRUBICIN | N | N | 260009791 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260014648 | 260014751 | null | 88.2 | Adjuvant (A) | 2016-10-30 | 2016-10-30 | Carboplatin 21day + Paclitaxel 7day | N | N | 260009791 | BLEOMYCIN + VINCRISTINE |
| 260014649 | 260010034 | 1.63 | 90 | null | 2017-07-18 | 2017-07-18 | Cyclophosphamide High Dose | null | null | 260009972 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260014650 | 260010035 | 1.86 | 50.1 | Palliative (P) | 2017-05-01 | 2017-05-12 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | 2 | N | 260010022 | METHOTREXATE HIGH DOSE |